Literature DB >> 6806377

Noncovalent association of heavy and light chains of human immunoglobulins. III. Specific interactions between VH and VL.

C Horne, M Klein, I Polidoulis, K J Dorrington.   

Abstract

Mildly reduced monoclonal human IgM proteins have been cleaved at cysteinyl residues to give VH fragments after S-cyanylation with 2-nitro-5-thiocyanobenzoic acid. The noncovalent interaction between the VH fragments and autologous kappa-chains was studied by ultraviolet difference spectroscopy and circular dichroism. A bimolecular complex was formed with an association constant in excess of 10(7) M-1 at 23 degrees C. Complex formation was accompanied by burial of tryptophan and tyrosine side-chains. In contrast to the studies with autologous species, the VH fragments did not associate with heterologous kappa-chains as judged both by difference spectroscopy and gel filtration using radiolabeled VH fragments. This specificity in the association between VH and VL has been attributed to interactions contributed to by residues in the third hypervariable region of VH encoded by the DH and JH genes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6806377

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Engineering upper hinge improves stability and effector function of a human IgG1.

Authors:  Boxu Yan; Daniel Boyd; Timothy Kaschak; Joni Tsukuda; Amy Shen; Yuwen Lin; Shan Chung; Priyanka Gupta; Amrita Kamath; Anne Wong; Jean-Michel Vernes; Gloria Y Meng; Klara Totpal; Gabriele Schaefer; Guoying Jiang; Bartek Nogal; Craig Emery; Martin Vanderlaan; Paul Carter; Reed Harris; Ashraf Amanullah
Journal:  J Biol Chem       Date:  2011-12-27       Impact factor: 5.157

2.  Diversity at the variable-joining region boundary of lambda light chains has a pronounced effect on immunoglobulin ligand-binding activity.

Authors:  T Azuma; V Igras; E B Reilly; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

3.  Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.

Authors:  P H Tan; B M Sandmaier; P S Stayton
Journal:  Biophys J       Date:  1998-09       Impact factor: 4.033

4.  Expression of a Functional zipFv Antibody Fragment and Its Fusions with Alkaline Phosphatase in the Cytoplasm of an Escherichia coli.

Authors:  Byung-Ung Hur; Hyo-Jung Choi; Jae-Bong Yoon; Sang-Hoon Cha
Journal:  Immune Netw       Date:  2010-04-30       Impact factor: 6.303

5.  Human IgG1 hinge fragmentation as the result of H2O2-mediated radical cleavage.

Authors:  Boxu Yan; Zac Yates; Alain Balland; Gerd R Kleemann
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

Review 6.  Immunoglobulin light chain amyloid aggregation.

Authors:  Luis M Blancas-Mejia; Pinaki Misra; Christopher J Dick; Shawna A Cooper; Keely R Redhage; Michael R Bergman; Torri L Jordan; Khansaa Maar; Marina Ramirez-Alvarado
Journal:  Chem Commun (Camb)       Date:  2018-09-20       Impact factor: 6.222

7.  MIB-MIP is a mycoplasma system that captures and cleaves immunoglobulin G.

Authors:  Yonathan Arfi; Laetitia Minder; Carmelo Di Primo; Aline Le Roy; Christine Ebel; Laurent Coquet; Stephane Claverol; Sanjay Vashee; Joerg Jores; Alain Blanchard; Pascal Sirand-Pugnet
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

8.  Complementary middle-down and intact monoclonal antibody proteoform characterization by capillary zone electrophoresis - mass spectrometry.

Authors:  Arseniy M Belov; Li Zang; Roberto Sebastiano; Marcia R Santos; David R Bush; Barry L Karger; Alexander R Ivanov
Journal:  Electrophoresis       Date:  2018-06-05       Impact factor: 3.535

9.  Antibody domain mutants demonstrate autonomy of the antigen binding site.

Authors:  T Simon; K Rajewsky
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

10.  Receptor editing: an approach by autoreactive B cells to escape tolerance.

Authors:  D Gay; T Saunders; S Camper; M Weigert
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.